Login
LivaNova PLC logo

LivaNova PLC

livanova.com

What Do They Do?

Sells heart-lung surgery equipment and related services to hospitals and surgical teams, and implanted nerve-stimulation systems for epilepsy and depression to healthcare providers.

How Do They Make Money?

Customers, mainly hospitals, healthcare institutions and distributors, pay for equipment and nerve-stimulation devices when customers receive the products; installation is paid for when provided, while service contracts are paid upfront or periodically over the contract term.

revenue
SegmentShareRevenue
Cardiopulmonary
Sold outright

57%
FY2022: 50%
Neuromodulation
Sold outright

43%
FY2022: 47%

Who Are Their Customers?

Hospitals, healthcare institutions and distributors are customers; LivaNova sells medical devices through direct sales representatives, agents and independent distributors.

Do Revenues Turn Into Profits?

Not on paper. It lost $242.5M in FY2025, but brought in more cash than it spent: $173.3M of free cash flow.

Operating income, FY2025
14% of revenue
▲ +55% vs FY2024 ($129.1M, 10%)
Net income, FY2025
−17% of revenue
▼ Turned to a loss vs FY2024 ($63.2M, 5%)
Free cash flow, FY2025
12% of revenue
▲ +27% vs FY2024 ($135.9M, 11%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +10%
vs $357.8M in Q3 FY2025
Net income
▲ +28%
vs $26.8M in Q3 FY2025
Cardiopulmonary share of revenue vs 56.8% in Q3 FY2025
  • Aug 5, 2026 Raises full-year revenue and adjusted earnings guidance Revenue-growth guidance rose to 8% to 9%, and adjusted diluted earnings guidance to $4.30 to $4.40; free-cash-flow guidance fell to $140 million to $160 million.

Growing. Revenue grew 34% in 4 years, from $1B in FY2021 to $1.4B in FY2025, about 8% a year.

Advanced Circulatory Support wound down The older report described Advanced Circulatory Support as a separate business selling temporary life-support products; the latest report says the former segment was wound down and includes its non-cannula results in Other.

Revenue over time
Cardiopulmonary Neuromodulation Advanced Circulatory Support
$2B$1B$0

Who Do They Compete With?

Competes with Terumo Medical, Maquet Medical Systems, Medtronic, Haemonetics, Spectrum Medical, and NeuroPace

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support